Meridigen‑BPD
Bronchopulmonary Dysplasia
PreclinicalActive
Key Facts
About Meridigen Biotech
Taiwanese MSC‑focused biotech developing neuro‑vascular and pulmonary cell therapies.
View full company profileTherapeutic Areas
Other Bronchopulmonary Dysplasia Drugs
| Drug | Company | Phase |
|---|---|---|
| BPD Program | AyuVis Research | Pre-clinical |